Double‐Blind Placebo‐Controlled Trial of Terazosin Effect on Blood Pressure and Urinary Output of Dopamine in Hypertensive Patients

The Journal of Clinical Pharmacology

Volumn 32, Issue 9, 1992, Pages 816-821

  Romero, E ^a   Angeli, M ^b   Velasco, M ^a   Azar, E ^a   Bueno, O ^a   Lema, G ^a   Morales, N ^a   Nuchi, Y ^a   Rasines, C ^a   Wagner, A ^a  

^a Vargas Hospital Caracas ^*  (Venezuela)

^b ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; DOPAMINE; NORADRENALIN; PLACEBO; TERAZOSIN;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CATECHOLAMINE EXCRETION; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOPAMINE URINE LEVEL; DOUBLE BLIND PROCEDURE; FEMALE; HEADACHE; HUMAN; HYPERTENSION; MALE; PULSE RATE; SYSTOLIC BLOOD PRESSURE; VERTIGO;

ADRENERGIC ALPHA-ANTAGONISTS; ADULT; AGED; BLOOD PRESSURE; COMPARATIVE STUDY; DOPAMINE; DOUBLE-BLIND METHOD; FEMALE; HUMAN; HYPERTENSION; MALE; MIDDLE AGE; PRAZOSIN; URINATION;

EID: 0026664896     PISSN: 00912700     EISSN: 15524604     Source Type: Journal    
DOI: 10.1002/j.1552-4604.1992.tb03888.x     Document Type: Article

References (26)

1. Dopamine decreases fluid reabsorption in straight portions of rabbit proximal tubule
2. The renal vasodilating effects of dopamine is mediated by calcium flux and prostacycline release in man
3. Urinary dopamine in man and rat: Effects of inorganic salt on Dopamine excretion
4. Dopamine production by isolated glomeruli and tubules from rat kidneys
5. Alpha adrenergic blocking properties of Terazosin
6. Overall safety of Terazosin as antihypertensive agent
7. Pharmacokinetics of Terazosin
8. Hypertensive vascular disease
9. A rapid simplified procedure for simultaneous assay of norepinephrine, dopamine and 5 hydroxy‐triptamine from discret brain areas
10. A study of the factors affecting the aluminum, trihydroxyndole procedure for the analysis of catecholamines
11. Hemodynamic changes at rest and during exercise in long‐term prazosin therapy of essential hypertension
12. The pharmacology of terazosin
13. Variacion de la respuesta tensional al tratamiento con placebo en pacientes con hipertension arterial leve y moderada
14. Ageing and the cardiovascular system
15. Decreased beta‐adrenoceptor responsiveness as related to age, blood pressure and plasma catecholamines in patients with essential hypertension
16. Prazosin
17. The acute hemodynamic effects of Terazosin (Abstr.)
18. Terazosin: An effective once‐a‐day antihypertensive agent and apparent beneficial effect on cholesterol
19. Effect of terazosin on serum lipids
20. Adrenergic effects on plasma lipoprotein metabolism: Speculation on mechanism of action
21. Effects of Prazosin and Propanolol on blood lipids and lipoproteins in hypertensive patients
22. Enhanced dopamine renal responsiveness in patients with hypertension
23. Implementation of SI units for clinical laboratory data
24. Alpha,‐antagonists in the treatment of hypertension